Amylyx Pharmaceuticals (AMLX)
36.64
-0.36 (0.97%)
Upcoming Events
Latest Headlines
Amylyx Pharmaceuticals Announces Completion of Enrollment in Global Phase 3 PHOENIX Trial of AMX0035 in ALS
February 2, 2023 9:00 AM - BizWire
Form 5 Amylyx Pharmaceuticals, For: Dec 31 Filed by: Morningside Venture Investments Ltd
January 11, 2023 4:08 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Yeramian Patrick D
January 10, 2023 7:23 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Cohen Joshua B
January 10, 2023 7:21 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: FRATES JAMES M
January 10, 2023 7:21 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Olinger Margaret
January 10, 2023 7:20 PM - SEC Filing
Form 4 Amylyx Pharmaceuticals, For: Jan 06 Filed by: Klee Justin B.
January 10, 2023 7:13 PM - SEC Filing
BofA Securities Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
January 5, 2023 6:20 AM - StreetInsider
Form 4 Amylyx Pharmaceuticals, For: Dec 30 Filed by: FRATES JAMES M
January 4, 2023 9:34 PM - SEC Filing
Form 8-K Amylyx Pharmaceuticals, For: Dec 01
December 6, 2022 4:07 PM - SEC Filing
Amylyx Pharmaceuticals to Participate in the Evercore ISI 5th Annual HealthCONx Conference
November 22, 2022 9:00 AM - BizWire
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $51 at Citi
November 11, 2022 3:59 AM - StreetInsider
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q3 EPS by 1c
November 10, 2022 5:01 PM - StreetInsider
Form 10-Q Amylyx Pharmaceuticals, For: Sep 30
November 10, 2022 4:15 PM - SEC Filing
Form 8-K Amylyx Pharmaceuticals, For: Nov 10
November 10, 2022 4:08 PM - SEC Filing
Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results
November 10, 2022 4:01 PM - BizWire
Full Article List
